KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma: Efficacy by PD-L1 expression and line of therapy.

Adil Daud; Christian U. Blank; Caroline Robert; Igor Puzanov; Erika Richtig; Kim Allyson Margolin; Steven O'Day; Marta Nyakas; Jose Lutzky; Ahmad A. Tarhini; Elaine McWhirter; Christian Caglevic; Peter Mohr; Michael Millward; Marcus O. Butler; Honghong Zhou; Kenneth Emancipator; Scot Ebbinghaus; Nageatte Ibrahim; Georgina V. Long

doi:10.1200/JCO.2016.34.15_suppl.9513

KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma: Efficacy by PD-L1 expression and line of therapy.

Adil Daud, Christian U. Blank, Caroline Robert, Igor Puzanov, Erika Richtig, Kim Allyson Margolin, Steven O'Day, Marta Nyakas, Jose Lutzky, Ahmad A. Tarhini, Elaine McWhirter, Christian Caglevic, Peter Mohr, Michael Millward, Marcus O. Butler, Honghong Zhou, Kenneth Emancipator, Scot Ebbinghaus, Nageatte Ibrahim, Georgina V. Long

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

12 Citations (Web of Science)

Original language	English
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	34
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2016.34.15_suppl.9513
Publication status	Published - 20 May 2016
Event	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 3 Jun 2016 → 7 Jun 2016

Access to Document

10.1200/JCO.2016.34.15_suppl.9513

Cite this

Daud, A., Blank, C. U., Robert, C., Puzanov, I., Richtig, E., Margolin, K. A., O'Day, S., Nyakas, M., Lutzky, J., Tarhini, A. A., McWhirter, E., Caglevic, C., Mohr, P., Millward, M., Butler, M. O., Zhou, H., Emancipator, K., Ebbinghaus, S., Ibrahim, N., & Long, G. V. (2016). KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma: Efficacy by PD-L1 expression and line of therapy. Journal of Clinical Oncology, 34(15). https://doi.org/10.1200/JCO.2016.34.15_suppl.9513

@article{7f595c40cd084cbaac8ae84b8d134136,

title = "KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma: Efficacy by PD-L1 expression and line of therapy.",

author = "Adil Daud and Blank, {Christian U.} and Caroline Robert and Igor Puzanov and Erika Richtig and Margolin, {Kim Allyson} and Steven O'Day and Marta Nyakas and Jose Lutzky and Tarhini, {Ahmad A.} and Elaine McWhirter and Christian Caglevic and Peter Mohr and Michael Millward and Butler, {Marcus O.} and Honghong Zhou and Kenneth Emancipator and Scot Ebbinghaus and Nageatte Ibrahim and Long, {Georgina V.}",

year = "2016",

month = may,

day = "20",

doi = "10.1200/JCO.2016.34.15_suppl.9513",

language = "English",

volume = "34",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ASCO ; Conference date: 03-06-2016 Through 07-06-2016",

}

Daud, A, Blank, CU, Robert, C, Puzanov, I, Richtig, E, Margolin, KA, O'Day, S, Nyakas, M, Lutzky, J, Tarhini, AA, McWhirter, E, Caglevic, C, Mohr, P, Millward, M, Butler, MO, Zhou, H, Emancipator, K, Ebbinghaus, S, Ibrahim, N & Long, GV 2016, 'KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma: Efficacy by PD-L1 expression and line of therapy.', Journal of Clinical Oncology, vol. 34, no. 15. https://doi.org/10.1200/JCO.2016.34.15_suppl.9513

TY - JOUR

T1 - KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma

T2 - Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

AU - Daud, Adil

AU - Blank, Christian U.

AU - Robert, Caroline

AU - Puzanov, Igor

AU - Richtig, Erika

AU - Margolin, Kim Allyson

AU - O'Day, Steven

AU - Nyakas, Marta

AU - Lutzky, Jose

AU - Tarhini, Ahmad A.

AU - McWhirter, Elaine

AU - Caglevic, Christian

AU - Mohr, Peter

AU - Millward, Michael

AU - Butler, Marcus O.

AU - Zhou, Honghong

AU - Emancipator, Kenneth

AU - Ebbinghaus, Scot

AU - Ibrahim, Nageatte

AU - Long, Georgina V.

PY - 2016/5/20

Y1 - 2016/5/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000404711507135&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1200/JCO.2016.34.15_suppl.9513

DO - 10.1200/JCO.2016.34.15_suppl.9513

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 34

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

Y2 - 3 June 2016 through 7 June 2016

ER -

KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma: Efficacy by PD-L1 expression and line of therapy.

Access to Document

Other files and links

Cite this